Accueil>>Signaling Pathways>> Neuroscience>> mAChR>>Timepidium bromide (Sesden)

Timepidium bromide (Sesden)

Catalog No.GC32666

Le bromure de timepidium (Sesden) (Sesden; SA504) est un agent anticholinergique.

Products are for research use only. Not for human use. We do not sell to patients.

Timepidium bromide (Sesden) Chemical Structure

Cas No.: 35035-05-3

Taille Prix Stock Qté
1mg
368,00 $US
En stock
5mg
735,00 $US
En stock
10mg
1 250,00 $US
En stock
20mg
2 206,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Timepidium bromide (Sesden; SA504) is an anticholinergic agent.

Effects of Timepidium bromide (TB), acetylcholine (ACh) and neostigmine (Neost) on gastric and duodenal blood flow distribution are studied by the use of 131I-labeled macroaggregated human serum albumin (MAA) in rabbits. In normal rabbits, gastric blood flow is found to be uneven in various regions of the stomach: anterior corpus (50% of total gastric blood flow) greater than posterior corpus (40%) greater than pyloric antrum (7%). Intravenous administration of Timepidium bromide (200 μg/kg) to normal rabbits produces a slight increase in total gastric blood flow, but the increase in the mucosal layer of the pyloric antrum is considerable[1].

[1]. Naito K, et al. Effect of timepidium bromide, an anticholinergic agent, on gastric and duodenal blood flow distribution in rabbits. Jpn J Pharmacol. 1982 Feb;32(1):73-80.

Avis

Review for Timepidium bromide (Sesden)

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Timepidium bromide (Sesden)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.